Life Sciences

Charter Capital Partners is highly involved in the life sciences technology sector, in both its M&A and capital raise activities. Charter principals manage the $15.1 million Michigan Accelerator Fund I (MAF-1), a venture capital fund investing in early-stage Michigan-based life sciences companies, as well as the $5 million MAF Opportunity Fund, aimed at investing further into elite MAF-1 portfolio companies.

Our depth of knowledge and involvement with key participants in the life sciences industry enable us to efficiently connect you with the right buyer, seller, or investor for your business.

HIGHLIGHTED TRANSACTIONS

Investment banking services for this $9.8 million debt and equity fundraising effort were provided by principals of Charter Capital Partners, acting as registered securities agents of M&A Securities Group.

Investment banking services for this $9.8 million debt and equity fundraising effort were provided by principals of Charter Capital Partners, acting as registered securities agents of M&A Securities Group.

MAF-1 invests in early stage Michigan-based companies, focusing primarily on life sciences technology. The fund currently includes seven portfolio companies.

MAF-1 invests in early stage Michigan-based companies, focusing primarily on life sciences technology. The fund currently includes seven portfolio companies.

Charter participated in a Series A capital investment. Playing an active co-lead investor role with Hopen Life Sciences and Hope River Ventures, Charter was instrumental in the completion of the funding to facilitate the commercial launch of the Intervention Insights business.

Charter participated in a Series A capital investment. Playing an active co-lead investor role with Hopen Life Sciences and Hope River Ventures, Charter was instrumental in the completion of the funding to facilitate the commercial launch of the Intervention Insights business.

ADDITIONAL